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Introduction
A myriad of explanations underpin the mechanisms pro-
posed for the LV annular dilatation following a myocar-
dial infarction that eventually lead to mitral regurgitation.
Most believe an active process drives remodeling of adja-
cent myocardium with subsequent secondary mitral
annular dilation. However, non-geometric, passive mecha-
nisms have not been considered as potential contributers
to either the mitral valve or the annular patholgy. Classic
CMR delayed hyperenhancement (DHE) describes a myr-
iad of LV myocardial histopathology but may also be sen-
sitive to non-myocardial pathology such as the annulus or
the mitral leaflets.
Hypothesis
We hypothesize that DHE may detect occult LV annular
and/or mitral valvular enhancement in post MI patients.
Methods
220 patients; 140 s/p MI (55 F, 50 acute, 90 chronic)
underwent CMR (1.5 T GE) with 0.2 mmol/kg of Magne-
vist (Berlex, Montville, New Jersey or 0.1 mmol/kg Multi-
Hance (Bracco Diagnostics, Princeton, New Jersey).
Notation of presence or absence of DHE involving the
mitral annulus and/or mitral valve was made. Non-MI
patientss (80) served as controls.
Results
All post-MI pts demonstrated infarct by DHE. Additional
DHE was present involving the mitral valve in 93 (67%)
but representing 86% of chronic MI's but only 11% of
acute MI's. Exactly 56 (40%) pts also had mitral annular
DHE. Lesser amounts of DHE signal was also seen in adja-
cent valves: aortic 31 (22%), tricuspid 43 (31%) while vir-
tually no DHE signal was seen along the tricuspid annulus
11 (7%). Only 7 (9%) of controls demonstrated any
degree of valvular DHE and 3 (4%) had annular DHE
(mostly myocarditis patients). Figure 1.
Conclusion
CMR DHE depicts focal annular and/or valvar enhance-
ment in a large number of post MI patients, suggesting a
specific, as yet unknown reactive process may contribute
to annular dilatation and/or mitral leaflet pathology. This
passive phenomena is currently not a suspected contribu-
tor to the post MI phenotype but may portend late LV dil-
atation and either primary or secondary mitral
regurgitation.
The Delayed Hyperenhancement phenomenon has been
well described for improved myocardial tissue characteri-
zation for infarct and non-infarct related pathologies. We
demonstrate that this same property of DHE appears to
delineate previously unrecognized properties within the
mitral valve in post-MI patients.
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